Viewing Expert Gordon Reid | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

Viewing Expert

Gordon Reid , President

GoodReid Investment Counsel

Address
47 Colborne Street
Suite 400
Toronto, ON
M5E 1P8

Contact Info
Telephone: 416.364.0890
Toll Free: 1.888.466.3734
Fax: 416.364.1788
Email:


Date Signal Chart Symbol Company Opinion Price
2017-08-17 N/A Must be logged in to use chart A Commentary A Comment -- General Comments From an Expert

Market. This has been an impressive earning season off the 1st quarter, which was actually more impressive. We were up over 15% in the 1st quarter and over 10% in the 2nd quarter. Earnings are certainly driving this market, and validating the market. The VIX has been at historic lows. Today, we saw the market paying attention to what was happening in Washington. The worry is that the exodus of CEOs in the last few days, might be followed by Trump’s inner circle within the White House. The US economy is on solid footing. Companies are investing and spending again. Far too much attention is paid to politics and policies. Companies are taking advantage of a resurgence in global growth. We are in the procyclical market, which tends to last for a while, and are in the early stages of that move.


Price:
$0.020
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
_N/A
2017-08-17 COMMENT Must be logged in to use chart AMGN-Q Amgen Inc.

A fabulous company and has done very well, but their drugs are very mature and make up a very large piece of their total revenue and portfolio. They are spending a lot of money on R&D which has some promise, but no guarantee that they are going to be able to replace the revenue flow. The stock is trading at about 12X earnings. Prefers something that has more current opportunities and a deeper pipeline.


Price:
$167.810
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Unknown
2017-08-17 COMMENT Must be logged in to use chart AMZN-Q Amazon.com

A bit of a tough analytical exercise. CEO truly marches to his own beat and doesn’t care what Wall Street analysts think about his results, and doesn’t view the calendar as some sort of reason to start or end. In many cases, corporate America has fallen prey to the short-term, myopic view of success, quarter to quarter to quarter. Business isn’t built that way. However, it is very difficult to understand or predict in what direction he is going. Cash flow is growing dramatically. Earnings are all over the place. Capital expenditures are skyrocketing. He would prefer Facebook (FB-Q) instead.


Price:
$960.570
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
No
2017-08-17 PAST TOP PICK Must be logged in to use chart BA-N Boeing

(A Top Pick September 7/16. Up 83.03%.) This has done fabulously well. They are in full production with the 737 and the 787, and has really become a cash flow story. Recently sold this based on “price exhaustion”, where a company does everything you expect of them, but the price rises to such a point that the valuation becomes extreme. Right now, it is trading at about 150% of its normalized multiple. It normally trades at 15-16 times earnings and is now trading at 23-24 times.


Price:
$235.590
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
No
2017-08-17 BUY Must be logged in to use chart BAC-N Bank of America

This is early days for this bank. It still trades well below BV. Earnings are going to really grow dramatically as the yield curve steepens and interest rates start to rise.


Price:
$23.640
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
2017-08-17 DON'T BUY Must be logged in to use chart CSX-Q CSX Corp

Hunter Harrison is controversial because he comes in with very strong ideas on how to create efficiencies and get operating ratios down. The multiple on the stock, in anticipation of Hunter Harrison coming in, grew to the point where it was probably trading at a 70%-80% premium to the normal multiple. They did a reasonable job in bringing the operating ratio down. He likes areas that are a little less controversial, where people work in a conciliatory way. The company has some inherent difficulties, such as a fairly large coal portfolio. He would look at Union Pacific (UNP-N) instead.


Price:
$48.880
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
No
2017-08-17 HOLD Must be logged in to use chart CVS-N CVS Health Corp

This whole space has been challenged, as well as a bit of an Amazon (AMZN-Q), but doubts that will happen. As we get older, people are taking more and more pills. However, we are moving away from patented medicines towards generics, which have lower margins attached to them. About a 3rd of their business is dedicated to a Pharmacy Benefit Manager, an insurance middleman, to act on behalf of individuals to get better prices. They have 10,000 locations in the US, including deals with Target. Bought Omnicare, which services old-age homes. Will write over a billion subscriptions in 2017.


Price:
$78.890
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
2017-08-17 PAST TOP PICK Must be logged in to use chart DY-N Dycom Industries

(A Top Pick September 7/16. Down 6.9%.) This is in the business of basically wiring North America for 1 Gb streaming of data transmission. We are all looking for “more”, which comes in the form of a more complex data packet, and certainly streaming. Everybody is getting into streaming and we are watching movies and TV shows on computers and mobile devices. We need the transmission infrastructure to do that, and this company does that. Management is confident that over the long-term, they can grow EBIT (earnings before interest and taxes) at a 15%-16% annual clip. This makes this a very compelling long-term buy. Be patient.


Price:
$80.540
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
2017-08-17 TOP PICK Must be logged in to use chart DY-N Dycom Industries

This company is going to do very well over time. Management thinks they can create a runway of 15% growth year-over-year in earnings before interest and taxes. The stock price doesn’t reflect that. We are going to have a wire line plant in the US. It has to happen. Management explains this as a decade long project. (Analysts’ price target is $115.)


Price:
$80.540
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
2017-08-17 COMMENT Must be logged in to use chart F-N Ford Motor

A tough space, simply because auto peak sales have shown themselves in North America. There is some resurgence in auto sales in Europe and emerging markets. Although this company is doing well on a unit basis, it isn’t doing all that well on profitability. The good news is that they are coming out with a refreshed F150, their backbone, which will be good for them.


Price:
$10.640
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Unknown
2017-08-17 DON'T BUY Must be logged in to use chart GE-N General Electric

This is at a crossroads. The CEO is on his way out. Revenues, over the last 15 years, grew a total of 7% per share, and cash flow and earnings were flat. The street is looking for close to $2 per share in 2018, and thinks that will be revised down significantly. The stock is starting to anticipate that and is falling from the high $20s into the mid $20s. He would rather buy this on the way up at $25-$27.


Price:
$24.750
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Unknown
2017-08-17 COMMENT Must be logged in to use chart GILD-Q Gilead Sciences Inc.

The potential for this company is for them to use their cash in a positive way. They have about $30 billion of cash on the balance sheet, which represents about 35% of their total market cap. This cash has been acquired because of their hepatitis C portfolio. The drug cures, but costs about $100,000 in the US. However, it is covered by most medical plans. Their opportunity is to make some good acquisitions with their cash hoard.


Price:
$72.340
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Unknown
2017-08-17 PAST TOP PICK Must be logged in to use chart HD-N Home Depot

(A Top Pick September 7/16. Up 14.66%.) This is benefiting from a variety of things, not the least of which is household formations and housing starts increasing. We are still below trend, which over the last 3, 4, 5 decades, has been between 1-2 million starts per year. We need 1-1.5 million to keep up with the growth of the population, and we are currently at about 1.1 million.


Price:
$149.670
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
2017-08-17 TOP PICK Must be logged in to use chart HON-N Honeywell International

A premier industrial. Great management and a strong balance sheet. They have about 38%-40% in aerospace. They provide products for the home, as well as to industrial operations. Dividend yield of 1.9%. (Analysts’ price target is $146.)


Price:
$135.850
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
2017-08-17 TOP PICK Must be logged in to use chart MS-N Morgan Stanley

This has sort of reinvented itself over the last couple of decades. It was primarily an institutional house, a fixed income house. Today, 44% of its business is on wealth management platform. Coming off the financial crisis, they bought Smith Barney from City. Putting those together and growing them, they are now a real force in the US in terms of wealth management. Expects earnings to grow 21% this year and 15% next year. Trading at about 1.2X Book, but well worth it. Dividend yield of 2.1%. (Analysts’ price target is $49.50.)


Price:
$45.090
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
Showing 1 to 15 of 2,014 entries
<< < 1 2 3 4 5 > >>

No Comments.


You must be logged in to comment.